<?xml version="1.0" encoding="UTF-8"?>
<p id="Par113">Results of covalent plasma and under development vaccines soon will indicate the value of these methods. Also, a new method is growing, Vanessa Monteil et al. (
 <ext-link ext-link-type="uri" xlink:href="https://www.cell.com/pb-assets/products/coronavirus/CELL_CELL-D-20-00739.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.cell.com/pb-assets/products/coronavirus/CELL_CELL-D-20-00739.pdf</ext-link>), indicated that SARS-CoV-2 spike protein straightly binds to ACE2 and they showed that the SARS-CoV-2 spike protein identifies human ACE2 with higher binding affinity than Spike from SARS-CoV.
</p>
